AMSTERDAM – Does pushing for a PASI 90 response instead of settling for a PASI 75 matter to patients being treated for moderate-to-severe chronic plaque psoriasis?
You bet it does, Dr. Mark G....
Rheumatoid arthritis patients treated with the biologic tocilizumab and the Janus kinase inhibitor tofacitinib had significant changes to their lipid levels in a meta-analysis of randomized,...
A tailored hand exercise program for rheumatoid arthritis patients proved to be a cost-effective intervention for restoring and maintaining hand function in a randomized trial.
Sarah E. Lamb,...
An international team of researchers has identified biomarkers that may help pinpoint rheumatoid arthritis patients at risk of interstitial lung disease.
Dr. Juan Chen of the First Hospital of...
Rheumatoid arthritis patients who have undergone a hip or knee replacement are more likely to be readmitted to a hospital than are patients with osteoarthritis, according to findings from a large...
The biosimilar age for rheumatology has arrived, and experts expect wider use of previously expensive biologic drugs as biosimilar competition drives prices down and makes biologics more...
Individuals with inflammatory rheumatic diseases such as inflammatory arthritis, vasculitis, and connective tissue diseases, have a threefold increase in the risk of venous thromboembolism, compared...
Physical therapy before joint replacement surgery cut the predicted use of postoperative care by 29%, saving an estimated $1,215 in health care costs per patient, according to a Medicare claims...
Psoriatic dactylitis might be caused by inflammation of the small enthesis pulleys of flexor tendons of affected fingers and toes, according a study using high-resolution MRI.
The findings help...
Combining tumor necrosis factor-alpha inhibitors with conventional disease-modifying antirheumatic drugs more than doubled the risk of shingles in patients with psoriatic arthritis, according to a...